Advertisement

Topics

Johnson and Johnson (France) Company Profile

13:44 EST 23rd November 2017 | BioPortfolio

Our pharmaceuticals companies offer medicines that treat many of the world's most serious and widespread diseases. These diseases range from cancer, HIV/AIDS and bacterial infections to schizophrenia, epilepsy, rheumatoid arthritis and psoriasis. In 2007, we invested $5.3 billion in the search for new ways to treat these diseases and many others. It’s all part of our commitment to helping you and the ones you love lead longer, healthier lives.

These companies are organized into three global business units:

Central Nervous System and Internal Medicine

This business unit develops medicines for an array of health problems, including central nervous system disorders, such as schizophrenia and epilepsy; metabolic diseases, such as diabetes; cardiovascular diseases; and infectious diseases.

B.I.O. (Biotechnology, Immunology & Oncology)

This business unit develops traditional and biologic medicines to treat autoimmune disorders, such as rheumatoid arthritis, psoriasis, and Crohn’s disease; a wide range of cancers; and blood disorders, such as anemia.

Virology

This business unit develops medicines for the treatment of infectious diseases, such as HIV/AIDS, hepatitis C and tuberculosis.

Location

rue camille desmoulins
issy les moulineaux cedex 9
F-92787
France

Contact

Phone: 33-155004174


News Articles [1461 Associated News Articles listed on BioPortfolio]

Johnson & Johnson Posting Notable Gain After Upgrade By Jefferies

NEW BRUNSWICK (dpa-AFX) - Shares of Johnson & Johnson (JNJ) have shown a notable move to the upside during trading on Wednesday, climbing by 2 percent. With the upward move, Johnson & Johnson has ...

Johnson & Johnson tops 2Q profit forecasts

This Tuesday, Sept. 13, 2016, file photo, shows Johnson & Johnson Band-Aid brand bandages in Surfside, Fla.

Johnson & Johnson: The Fundamentals of Alliance Management

Johnson & Johnson were one of the first companies to realise the importance of an alliance management group closely following in rival Eli Lilly & Co.’s footsteps. Rob Wills, VP Alliance Management ...

A Corporate Law Takeaway From Judge Nelson's Ruling In The Talcum Powder Case

After a three week trial that included extensive expert testimony, a Los Angeles jury returned a $417 million verdict against Johnson & Johnson and its subsidiary Johnson & Johnson Consumer, I...

Johnson & Johnson: Wait For The Drop Or Take The Shot?

This company tracks the S&P 500 index heavily, and thus waiting for a pullback may not be a feasible strategy in a bullish marketplace. Johnson & Johnson has undoubtedly had quite a good ride ...

4 Things That Matter When Johnson & Johnson Reports Its Second-Quarter Results

It's that time again, folks: Earnings season is kicking into full swing. And with that comes healthcare conglomerate Johnson & Johnson 's Johnson & Johnson is set to report its second-...

Patient motivation platform debuted by J&J

The Johnson & Johnson Health Partner platform was launched by Johnson & Johnson for use in providing patients with personal m -More- 

Johnson & Johnson, HHS partner on influenza

Johnson & Johnson announced that Janssen Research & Development are collaborating with the HHS’ Office of the Assistant Secretary for Preparedness and Response (ASPR) to develop a comprehens...

PubMed Articles [250 Associated PubMed Articles listed on BioPortfolio]

Cefepime Associated With Phenytoin Induced Stevens-Johnson Syndrome.

We describe a recent case of Stevens-Johnson Syndrome. A 49-year-old man was admitted to the Intensive Care Unit of an Anaesthesia and Resuscitation Department because of a Fournier gangrene that deri...

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.

Although rare, Stevens-Johnson syndrome and toxic epidermal necrolysis remain among the most devastating of acute conditions involving the skin. In the past 30 years, tremendous progress has been made...

Are steroids effective in toxic epidermal necrolysis and Stevens-Johnson syndrome?

Toxic epidermal necrolysis and Stevens-Johnson syndrome are severe adverse skin reactions to medications and infections. Steroids are described as a therapeutic alternative, but their use is still con...

Role of Scleral Contact Lenses in Management of Coexisting Keratoconus and Stevens-Johnson Syndrome.

To report the rare coexistence of keratoconus and Stevens-Johnson syndrome (SJS) managed with scleral contact lenses (ScCLs).

Characterization of Children With Recurrent Episodes of Stevens Johnson Syndrome.

We performed a retrospective chart review for all cases of recurrent Stevens Johnson Syndrome (SJS) from March 2013 to March 2016. Nine children had 29 episodes of SJS or incomplete SJS; all children ...

Clinical Trials [554 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

Companies [471 Associated Companies listed on BioPortfolio]

Johnson and Johnson

Johnson & Johnson, employing approximately 119,000 people worldwide, is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnso...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early i...

Johnson & Johnson (China) Investment Co., Ltd.

Johnson & Johnson (China) Investment Co., Ltd. is a foreign investment entity established in China by Johnson & Johnson in 1998. For more information about Johnson & Johnson and its operating unit...

JOHNSON'S(R) Brand

JOHNSON'S® Brand from Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc., has a long tradition of providing pure, mild, gentle and clinically-proven p...

JANSSEN-ORTHO INC

Since 1961 Janssen-Cilag has been a member of the Johnson & Johnson family of companies. Founded in 1886, Johnson & Johnson today is the world's most comprehensive manufacturer of healthcare products ...

More Information about "Johnson and Johnson (France)" on BioPortfolio

We have published hundreds of Johnson and Johnson (France) news stories on BioPortfolio along with dozens of Johnson and Johnson (France) Clinical Trials and PubMed Articles about Johnson and Johnson (France) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Johnson and Johnson (France) Companies in our database. You can also find out about relevant Johnson and Johnson (France) Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...


Corporate Database Quicklinks



Searches Linking to this Company Record